8 employees
Inmunomet is a private medical group specialized in intolerances and gut dysbiosis related disorders with strong experience on the clinic.
$1.6M sweet spot round size
Most of their 1 investments are in rounds between $1.6M and $1.6M
2018
Microviable Therapeutics SL raised $1.6M on April 19, 2022
Investors: Inmunomet Intolerancia y Disbiosis